Thrombolytic therapy and clinical effects of urokinase
YANG Xue-Yi, HAN Bao-Fu (Shanghai Zhongshan Hospital and Shanghai Institute of Cardiovascular Diseases, Shanghai Medical University, Shanghai 200032)
Thrombo-embolism diseases were mostly coronary occlusion, cerebrovascu-lar thrombosis and peripheral arterial or venous thrombosis. The main cause of savage and death was thrombolism, the disease incidence is continually rising. Thrombolytic therapy is closely concentrated in clinic. We mainly introduce the mechanism of throm-bolysis by urokinase, clinical utility, therapeutic method, adverse reaction and contraindication. The clinical utility of the throrabolytic agent is evaluated.